BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
C10orf107 | Chromosome 10 open reading frame 107 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf126 | Chromosome 10 open reading frame 126 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf67 | Chromosome 10 open reading frame 67 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf60 | Chromosome 12 open reading frame 60 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C17orf97 | Chromosome 17 open reading frame 97 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C19orf57 | Chromosome 19 open reading frame 57 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C2orf82 | Chromosome 2 open reading frame 82 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C6orf132 | Chromosome 6 open reading frame 132 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf52 | Chromosome 6 open reading frame 52 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C7orf57 | Chromosome 7 open reading frame 57 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CA13 | Carbonic anhydrase XIII | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CADM4 | Cell adhesion molecule 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
CADPS | Ca++-dependent secretion activator | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPN3 | Calpain 3, (p94) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV2 | Caveolin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC113 | Coiled-coil domain containing 113 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC146 | Coiled-coil domain containing 146 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC151 | Coiled-coil domain containing 151 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC178 | Coiled-coil domain containing 178 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC181 | Coiled-coil domain containing 181 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC37 | Coiled-coil domain containing 37 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC40 | Coiled-coil domain containing 40 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC8 | Coiled-coil domain containing 8 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |